Briant F. Fruth

机构：Mayo Clinic, Alliance for Clinical Trials in Oncology, Mayo Clinic in Arizona, Mayo Clinic in Florida

发表论文 72 篇 · 总被引 3277 次 · h-index 15

代表论文

• Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial (2021 · Journal of Clinical Oncology · 被引 133)
• Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction (2022 · Clinical Cancer Research · 被引 75)
• MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma (2021 · International Journal of Radiation Oncology*Biology*Physics · 被引 54)
• Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial (2023 · The Lancet Oncology · 被引 32)
• De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial (2025 · The Lancet Oncology · 被引 26)
• How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians (2021 · Journal of Neuro-Oncology · 被引 21)